Structure-based Drug Design on CrossDock 2020 (test)
93.4PB ValidEvoEGF-Mol
Evaluation Results
| Method | Links | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EvoEGF-MolCategory=Geodesic Flow-based2026.01 | 93.4 | -6.14 | -6.89 | -6.98 | -7.12 | -7.72 | -7.88 | 8.94 | 25.96 | 56.65 | 97.1 | 0.53 | 0.75 | 24 | |
| MolCRAFTCategory=BFN-based2026.01 | 84.6 | -6.55 | -6.95 | -7.21 | -7.14 | -7.67 | -7.82 | 83 | 195 | 510 | 96.7 | 0.5 | 0.67 | 26 | |
| Pocket2MolCategory=Autoregressive-based2026.01 | 72.3 | -5.14 | -4.7 | -6.42 | -5.82 | -7.15 | -6.79 | 102 | 189 | 374 | 96.3 | 0.57 | 0.76 | 56 | |
| DecompDiffCategory=Diffusion-based2026.01 | 71.7 | -5.19 | -5.27 | -6.03 | -6 | -7.03 | -7.16 | 115 | 421 | 1,424 | 82.9 | 0.51 | 0.66 | 51 | |
| ARCategory=Autoregressive-based2026.01 | 59 | -5.75 | -5.64 | -6.18 | -5.88 | -6.75 | -6.62 | 259 | 595 | 2,286 | 93.5 | 0.51 | 0.63 | 22 | |
| TargetDiffCategory=Diffusion-based2026.01 | 50.5 | -5.47 | -6.3 | -6.64 | -6.83 | -7.8 | -7.91 | 369 | 1,243 | 13,871 | 90.4 | 0.48 | 0.58 | 53 |